Sanofi raised the U.S. wholesale price of its Lantus vials by almost 15 percent to $16.64 per milliliter and of its Lantus Solostar injection pens by almost 10 percent to $18.38 per milliliter, Jack Cox, a spokesman for Paris-based Sanofi, said in an e-mail. Those increases followed a 10 percent price increase in April for […]
MannKind Corp said results of two late-stage studies showed that its experimental diabetes therapy was more effective than injected insulin and oral treatments, sending its shares up 30 percent in premarket trading.
The Medicines and Healthcare Products Regulatory Agency said the strips should not be used because they could give inaccurate results, leading to a patient injecting too much insulin.
The study evaluated the effects of a combination of bariatric procedure with intensive medical therapy (IMT) versus intensive medical therapy alone based on beta cell function and body composition
According to Ralph Ziegler, MD, of the Diabetes Clinic for Children and Adolescents in Muenster, Germany, and colleagues, in the first results of a randomized trial, more than half of the volunteers using the automated bolus adviser saw improvement in their A1C’s.
This is part of a bigger push the FDA is making to encourage consumers to go through official agency channels to bring these product concerns to light, and “pressure” manufacturers to pay attention and respond.
A new study reports that the small intestine uses more cells than scientists had realized to absorb microspheres large enough to contain therapeutic protein drugs, such as insulin. The finding in rats, published in the Proceedings of the National Academy of Sciences, is potentially good news for developing a means for oral delivery of such […]
Higher blood-sugar levels, even those well short of diabetes, seem to raise the risk of developing dementia, a major new study finds. Researchers say it suggests a novel way to try to prevent Alzheimer’s disease — by keeping glucose at a healthy level.
There is no evidence that patients with diabetes who initiate insulin glargine have a higher risk of cancer than similar patients initiating human neutral protamine Hagedorn (NPH) insulin, according to a study published online July 22 in Diabetes Care.
Currently we have three basal insulins available in the United States: Lantus®, Levemir® and NPH. (Lantus® and Levemir® are brand names, NPH is a generic) Lantus® and Levemir® are categorized as long-acting insulins because they can be given once- a -day to cover a 24-hour period.
Of about 2,200 people who answered a question about the strips as part of a survey for Diabetes UK, 39% had had prescriptions refused or restricted. It says restrictions are being imposed by local health managers to save money.
Incidence of severe hypoglycemia was common in 10.8% of diabetic patients surveyed, with rates of hypoglycemia ranging from 9.3% to 13.8% across all levels of HbA1c, according to Kasia Lipska, MD, of Yale University, and colleagues.
Patients with diabetes who take certain types of medications to lower their blood sugar sometimes experience severe low blood-sugar levels, whether or not their diabetes is poorly or well controlled, according to a new study by Kaiser Permanente and Yale University School of Medicine.
Certain diabetes blood sugar testing strips are being recalled by their maker, Nova Diabetes Care, because they may give users false, abnormally high readings, according to the U.S. Food and Drug Administration.
In the early 1930’s, scientists isolated stevioside and rebaudioside, the ingredients that give stevia its sweetness. These ingredients, collectively known as glycosides, are about 300 times sweeter than sugar, but they are calorie-free and carbohydrate-free
My overall impression of the Nova Max is of a good meter that may have a bit of a problem finding an audience. When I started to think about whom Nova Biomedical is selling to, I got stuck. The disparate features of the NovaMax can lead to some identity confusion.
If I use insulin will my pancreas get lazy? How do I adjust my insulin injections for medical procedures? What are the best injection sites?
Clinical trials go well in 2013, its CEO expects to initiate the process of seeking Food and Drug Administration (FDA) approval for the device in 2014. And if that goes well, Worcester, Mass.-based Grove Instruments’ product could become available for use by the 25.8 million U.S. children and adults with diabetes by 2015 or 2016.
Oral insulins have been a dream of both patients and researchers for decades. But the technical aspects of preventing insulin from being digested by the enzymes in the gastrointestinal tract, along with the numerous barriers to absorption from the intestine, have been formidable.
Now a collaboration between North Carolina State University, University of North Carolina at Chapel Hill, MIT, and Boston Children’s Hospital has developed and is analyzing a new material that can encapsulate insulin and release it as needed into the blood stream.